Earlier clozapine or usual care after initial treatment failure in schizophrenia
About this title
Read the official source — NCT05958875Researchers are comparing Clozapine and Second-line Antipsychotics (treatment as usual) to find out how the approaches affect psychotic symptoms in people with schizophrenia.
Understand this study
What is this study about?
Researchers are comparing Clozapine and Second-line Antipsychotics (treatment as usual) to find out how the approaches affect psychotic symptoms in people with schizophrenia.
Who could participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
- Listed locations
- Innsbruck and 12 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 418
- Sponsor
- Dr. Inge Winter
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United Kingdom, Austria, Germany, ...
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT05958875
- Official title
Show the full official title
A Randomised, Controlled Trial to Investigate the Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Recruitment & locations
Innsbruck, Austria · Augsburg, Germany · Bielefeld, Germany
10 more locations
- Dortmund, Germany
- Frankfurt am Main, Germany
- Mainz, Germany
- Münster, Germany
- Brescia, Italy
- Cagliari, Italy
- Naples, Italy
- Turin, Italy
- Barcelona, Spain
- London, United Kingdom
Interested in joining this study?
Questions about this study
What is this study about?
Researchers are comparing Clozapine and Second-line Antipsychotics (treatment as usual) to find out how the approaches affect psychotic symptoms in people with schizophrenia.
Who is behind this study?
The study sponsor is Dr. Inge Winter.
Does this study involve medication?
Yes. The study involves medication, including Clozapine.
Who can participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
